Table 3 Cox regression analysis for disease-free and overall survival in tamoxifen-treated, hormone receptor positive patients
Disease-free survival analysis | Overall survival analysis | |||||||
|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
Variable | P | RR (95% CI) | P | RR (95% CI) | P | RR (95% CI) | P | RR (95% CI) |
Grading | 0.151 | 1.7 (0.82–3.16) | - | - | 0.015 | 2.81 (1.22–6.5) | 0.025 | 2.69 (1.13–6.4) |
Lymph node status | 0.284 | 1.89 (0.59–6.03) | - | - | 0.055 | 3.81 (1.02–14.3) | - | - |
Tumour size | 0.013 | 2.25 (1.18–4.26) | 0.023 | 2.24 (1.12–4.5) | 0.002 | 3.43 (1.56–7.56) | 0.005 | 3.83 (1.51–9.72) |
FasL : Fas ratio | 0.013 | 3.4 (1.29–8.96) | 0.027 | 3.0 (1.14–7.9) | 0.042 | 3.59 (1.05–12.3) | 0.043 | 3.65 (1.04–12.8) |